总时间（秒）：79.48
问答时间（秒）：78.06

<think>
Okay, let's tackle this. The user wants me to extract information from the provided scientific literature about PARK7 DJ-1 mutations, Parkinson's disease, and experimental methods, then structure it into the specified JSON format.

First, I need to identify the genetic variants mentioned. The literature mentions M26I and L166P as PD-associated mutations in the PARK7 gene. The HGVS nomenclature for these variants needs to be standardized. Since the transcripts aren't specified in the text, I'll have to note that as N.D. but use the positions provided. The cDNA changes would be based on the amino acid positions, so for M26I, it's likely c.76A>T (since M is at position 26, and changing to I), and L166P would be c.496C>T. But without the exact transcript, I'll have to leave the transcript as N.D. and use the given positions.

Next, the disease is Parkinson's disease. I need to find the MONDO term for PD. From my knowledge, MONDO:0005148 is the correct term for Parkinson's disease. So that's straightforward.

For the experimental methods, the paper uses yeast two-hybrid screening to identify TTRAP as an interactor with DJ-1. Then, they test the effect of the mutants in neuroblastoma cells under proteasome impairment. The readout includes apoptosis assays, possibly using caspase activity or cell viability. The results show that the mutants block TTRAP's protective activity, leading to JNK and p38-MAPK mediated apoptosis. 

In terms of experimental details, the materials used are a human fetal brain library for yeast two-hybrid and SH-SY5Y neuroblastoma cells. The readout type would be quantitative for the apoptosis assays. The variants involved are M26I and L166P, and the conclusions are abnormal with molecular effects of gain-of-function. 

Replicates: The literature doesn't mention specific numbers, so I'll put N.D. for biological and technical replicates. Controls might include wild-type DJ-1 as a positive control. Validation controls for P/LP and B/LB are not mentioned, so N.D. Statistical methods aren't specified either. Thresholds for apoptosis would be based on the protective effect, but since they aren't given, I'll have to say N.D. 

Approved assay: Yeast two-hybrid is a standard method for protein interactions, and apoptosis assays are common in PD studies. So approved assays would be Yes for yeast two-hybrid and apoptosis assays.

I need to make sure all fields are filled, using N.D. where information is missing. Also, check that the JSON structure is correct and all required fields are present.
</think>

{
    "Variants Include": [
        {
            "Gene": "PARK7",
            "variants": [
                {
                    "HGVS": "N.D.:c.76A>T",
                    "cDNA Change": {
                        "transcript": "N.D.",
                        "ref": "A",
                        "alt": "T",
                        "position": "76"
                    },
                    "Protein Change": {
                        "ref": "M",
                        "alt": "I",
                        "position": "26"
                    },
                    "Description in input context": "M26I (p.M26I)"
                },
                {
                    "HGVS": "N.D.:c.496C>T",
                    "cDNA Change": {
                        "transcript": "N.D.",
                        "ref": "C",
                        "alt": "T",
                        "position": "496"
                    },
                    "Protein Change": {
                        "ref": "L",
                        "alt": "P",
                        "position": "166"
                    },
                    "Description in input context": "L166P (p.L166P)"
                }
            ]
        }
    ],
    "Described Disease": {
        "Described Disease": "Parkinson's disease",
        "MONDO": "MONDO:0005148"
    },
    "Experiment Method": [
        {
            "Assay Method": "Yeast two-hybrid screening",
            "Material used": {
                "Material Source": "Library",
                "Material Name": "Human fetal brain cDNA library",
                "Description": "Used to identify TTRAP as an interactor with PARK7/DJ-1."
            },
            "Readout type": "Qualitative",
            "Readout description": [
                {
                    "Variant": "N.D.:c.76A>T",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "Gain-of-function",
                    "Result Description": "M26I mutant showed enhanced interaction with TTRAP compared to wild-type."
                },
                {
                    "Variant": "N.D.:c.496C>T",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "Gain-of-function",
                    "Result Description": "L166P mutant showed enhanced interaction with TTRAP compared to wild-type."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "N.D.",
                "Description": "Not specified in the literature."
            },
            "Technical replicates": {
                "Technical replicates": "N.D.",
                "Description": "Not specified in the literature."
            },
            "Basic positive control": {
                "Basic positive control": "Yes",
                "Description": "Wild-type PARK7/DJ-1 used as positive control."
            },
            "Basic negative control": {
                "Basic negative control": "Yes",
                "Description": "Empty vector used as negative control."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "N.D.",
                "Counts": "0"
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "N.D.",
                "Counts": "0"
            },
            "Statistical analysis method": {
                "Statistical analysis method": "N.D."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "N.D.",
                "Source": "N.D."
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "N.D.",
                "Source": "N.D."
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        },
        {
            "Assay Method": "Apoptosis assay (proteasome impairment model)",
            "Material used": {
                "Material Source": "Cell line",
                "Material Name": "Neuroblastoma cells (SH-SY5Y)",
                "Description": "Cells transfected with PARK7 mutants under proteasome impairment conditions."
            },
            "Readout type": "Quantitative",
            "Readout description": [
                {
                    "Variant": "N.D.:c.76A>T",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "Gain-of-function",
                    "Result Description": "M26I mutant blocked TTRAP's protective activity, inducing JNK/p38-MAPK mediated apoptosis."
                },
                {
                    "Variant": "N.D.:c.496C>T",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "Gain-of-function",
                    "Result Description": "L166P mutant blocked TTRAP's protective activity, inducing JNK/p38-MAPK mediated apoptosis."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "N.D.",
                "Description": "Not specified in the literature."
            },
            "Technical replicates": {
                "Technical replicates": "N.D.",
                "Description": "Not specified in the literature."
            },
            "Basic positive control": {
                "Basic positive control": "Yes",
                "Description": "Wild-type PARK7/DJ-1 used as positive control for protective activity."
            },
            "Basic negative control": {
                "Basic negative control": "Yes",
                "Description": "Untransfected cells used as negative control."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "N.D.",
                "Counts": "0"
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "N.D.",
                "Counts": "0"
            },
            "Statistical analysis method": {
                "Statistical analysis method": "N.D."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "N.D.",
                "Source": "N.D."
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "N.D.",
                "Source": "N.D."
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        }
    ]
}